| Lactose (India) Ltd | 122 Cr. | 97.0 | 197/84.3 | 27.0 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.21 Cr. | 1.68 | 4.29/1.68 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 3,466 Cr. | 316 | 479/192 | 71.8 | 24.3 | 0.21 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 34.2 Cr. | 46.1 | 83.2/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 64.1 Cr. | 43.7 | 43.7/17.0 | 153 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 70.5 Cr. | 93.6 | 115/69.7 | 19.0 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 55,529 Cr. | 1,968 | 2,286/1,275 | 22.1 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 294 Cr. | 12.1 | 17.2/10.8 | 17.6 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.09 Cr. | 12.0 | 14.8/9.25 | 88.6 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 798 Cr. | 1,488 | 1,999/635 | 27.6 | 334 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 91.0 Cr. | 18.2 | 29.8/17.0 | 24.9 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 934 Cr. | 317 | 449/219 | 8.34 | 133 | 0.79 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 3.07 Cr. | 14.6 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 7.77 Cr. | 3.12 | 8.28/2.11 | 4.41 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 406 Cr. | 418 | 536/211 | 61.3 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,910 Cr. | 1,129 | 1,565/944 | 44.4 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 42.9 Cr. | 0.21 | 1.12/0.20 | 2.83 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 30.5 Cr. | 11.6 | 26.3/11.2 | 14.9 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 7.58 Cr. | 7.50 | 15.2/7.50 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 155 Cr. | 435 | 851/415 | 8.80 | 596 | 0.34 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 70.4 Cr. | 70.4 | 92.5/26.1 | 133 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 12,800 Cr. | 1,222 | 2,452/1,211 | 39.8 | 174 | 0.88 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 7.00 Cr. | 55.5 | 88.7/36.1 | 14.3 | 39.2 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.5 Cr. | 5.01 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 19.6 Cr. | 131 | 153/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 66.5 Cr. | 122 | 144/9.41 | 45.9 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 30.6 Cr. | 40.5 | 73.0/33.0 | 49.3 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.27 Cr. | 20.9 | 24.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 7,269 Cr. | 420 | 1,028/416 | 20.6 | 72.4 | 0.29 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 74.3 Cr. | 17.2 | 29.6/16.6 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.3 Cr. | 22.2 | 37.7/17.4 | 49.0 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 86,649 Cr. | 2,094 | 2,727/2,059 | 52.0 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 219 Cr. | 380 | 524/241 | 22.4 | 123 | 1.18 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 58.5 Cr. | 40.8 | 47.9/26.7 | 91.4 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 65,576 Cr. | 1,130 | 1,279/994 | 19.2 | 603 | 0.35 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 129 Cr. | 207 | 303/159 | 123 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 712 Cr. | 71.0 | 115/68.0 | 18.4 | 32.6 | 2.11 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 31.7 Cr. | 24.3 | 42.8/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 14,164 Cr. | 1,728 | 1,902/919 | 63.2 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.03 Cr. | 0.61 | 1.06/0.51 | 101 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 183 Cr. | 23.8 | 53.8/23.4 | 11.7 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 7.20 Cr. | 12.3 | 19.1/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 128 Cr. | 5.43 | 6.57/2.82 | | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 58,725 Cr. | 27,685 | 37,000/25,260 | 38.9 | 1,888 | 1.72 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,996 Cr. | 766 | 972/557 | 29.2 | 226 | 0.65 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 192 Cr. | 67.9 | 100/31.3 | 53.8 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,250 Cr. | 1,281 | 1,740/752 | | 103 | 0.08 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 22,006 Cr. | 1,349 | 1,870/1,110 | 401 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 572 Cr. | 163 | 330/154 | 13.3 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 63.8 Cr. | 7.68 | 29.4/6.65 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 982 Cr. | 748 | 849/270 | 15.5 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 2,573 Cr. | 367 | 760/361 | 17.7 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,354 Cr. | 960 | 1,402/951 | 19.4 | 768 | 1.04 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,35,471 Cr. | 3,997 | 4,125/2,886 | 62.5 | 250 | 0.80 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 720 Cr. | 77.7 | 255/76.0 | | 41.3 | 0.64 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,106 Cr. | 11.8 | 23.5/11.5 | 17.6 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 14,354 Cr. | 375 | 1,328/369 | 41.8 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 2,895 Cr. | 127 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 3,93,287 Cr. | 1,639 | 1,851/1,547 | 34.1 | 324 | 0.98 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,267 Cr. | 514 | 734/441 | 354 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,790 Cr. | 299 | 360/175 | 34.4 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 5,260 Cr. | 268 | 502/260 | 34.0 | 125 | 0.19 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,464 Cr. | 4,114 | 6,718/3,976 | 25.6 | 340 | 2.84 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,477 Cr. | 2,102 | 2,725/1,772 | 31.2 | 335 | 0.95 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,973 Cr. | 5,405 | 6,739/4,904 | 29.2 | 373 | 2.31 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 154 Cr. | 43.8 | 76.2/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 21,059 Cr. | 4,608 | 5,993/3,701 | 29.8 | 841 | 0.76 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 110 Cr. | 89.3 | 206/81.0 | 11.3 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,129 Cr. | 348 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,572 Cr. | 706 | 1,512/604 | 68.4 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 16,425 Cr. | 12,796 | 19,748/10,060 | 83.9 | 1,263 | 0.09 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 270 Cr. | 14.0 | 38.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 14,588 Cr. | 814 | 1,341/660 | 9.48 | 483 | 0.74 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 1,861 Cr. | 34.0 | 70.5/33.5 | 24.6 | 21.8 | 0.59 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 7,312 Cr. | 161 | 276/158 | 20.8 | 59.3 | 0.50 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 66.7 Cr. | 42.2 | 123/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 264 Cr. | 73.3 | 157/71.3 | 129 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 98,237 Cr. | 2,150 | 2,228/1,774 | 22.7 | 430 | 0.56 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 901 Cr. | 450 | 809/443 | 11.3 | 357 | 0.40 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 53,957 Cr. | 1,000 | 1,141/504 | 67.4 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,093 Cr. | 1,053 | 1,235/596 | 22.3 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 123 Cr. | 56.9 | 114/54.9 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 617 Cr. | 128 | 215/123 | 37.3 | 104 | 2.35 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 553 Cr. | 316 | 500/265 | 20.1 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 14,979 Cr. | 939 | 1,250/802 | 30.1 | 414 | 0.53 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 30,203 Cr. | 1,878 | 1,939/1,303 | 40.1 | 243 | 0.83 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,095 Cr. | 164 | 302/155 | 25.7 | 37.9 | 1.53 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 36,905 Cr. | 1,455 | 1,595/1,168 | 37.3 | 293 | 0.27 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,041 Cr. | 69.7 | 127/57.5 | 17.6 | 59.7 | 1.15 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 20.9/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 879 Cr. | 107 | 124/67.2 | 29.6 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,020 Cr. | 219 | 350/190 | | 106 | 0.09 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,395 Cr. | 194 | 457/190 | 237 | 96.9 | 0.72 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,193 Cr. | 1,405 | 2,350/1,243 | 27.2 | 397 | 0.50 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,005 Cr. | 300 | 460/285 | 55.4 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 14,054 Cr. | 579 | 627/412 | 25.9 | 164 | 0.26 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 56,344 Cr. | 2,000 | 2,286/1,275 | 22.4 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 39,687 Cr. | 2,341 | 3,516/1,921 | 41.6 | 101 | 1.79 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 27,621 Cr. | 1,676 | 2,131/1,200 | 23.9 | 610 | 1.07 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 5,986 Cr. | 367 | 528/359 | 26.6 | 149 | 1.36 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 18,597 Cr. | 1,343 | 1,910/1,097 | 44.7 | 227 | 0.55 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,03,515 Cr. | 1,240 | 1,380/1,020 | 18.6 | 432 | 0.65 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,150 Cr. | 203 | 322/178 | 21.1 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,06,072 Cr. | 1,313 | 1,673/1,282 | 22.3 | 408 | 0.99 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 13,166 Cr. | 1,731 | 2,397/1,551 | 22.4 | 416 | 0.35 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 185 Cr. | 63.2 | 166/62.6 | 13.2 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,769 Cr. | 167 | 196/105 | 16.1 | 107 | 0.30 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 47.9 Cr. | 29.4 | 58.0/28.5 | 16.8 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 59,171 Cr. | 365 | 425/291 | 125 | 200 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,513 Cr. | 1,498 | 2,000/1,430 | 33.4 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 108 Cr. | 68.5 | 129/65.7 | 15.8 | 49.2 | 1.75 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 281 Cr. | 118 | 205/67.8 | 26.6 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 20,906 Cr. | 8,349 | 10,691/6,502 | 90.4 | 320 | 0.38 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,703 Cr. | 591 | 791/544 | 30.0 | 118 | 0.78 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 132 Cr. | 63.0 | 125/61.0 | 7.03 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 68,852 Cr. | 5,754 | 5,934/4,492 | 29.3 | 1,116 | 0.78 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 14,925 Cr. | 757 | 1,108/725 | 23.5 | 271 | 1.45 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 386 Cr. | 675 | 1,219/670 | | 690 | 0.74 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 33,710 Cr. | 2,698 | 3,080/2,022 | 34.6 | 345 | 1.04 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 2,977 Cr. | 266 | 367/258 | 20.2 | 133 | 1.95 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,353 Cr. | 368 | 575/312 | 17.6 | 147 | 0.27 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 19,551.42 Cr | 1,082.84 | | 47.19 | 202.32 | 0.38% | 16.29% | 15.20% | 6.10 |